RxDoctor Payments Data

Ted Edwards, DO

Interventional Pain Medicine · Huntsville, ALNPI 1932189560

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for interventional pain medicine clinicians in AL, where the typical reported total is $4,812.

$2,492in general payments, 2019–2025

Across 120 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$296
  • Neurocrine Biosciences, Inc.$271
  • AstraZeneca$253
  • Eisai Inc.$223
  • Argenx US, Inc.$219
  • AbbVie$203
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$2,492100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,492 in reported general payments places this provider in the 30th percentile of 33 interventional pain medicine providers in Alabama.

See all interventional pain medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$196,704
Medicare patients
82
Services billed
2,946

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen810$18,296
Tramadol Hcl ErTramadol Hcl86$4,552
Lidocaine28$3,945
Morphine Sulfate ErMorphine Sulfate97$2,706
Tizanidine Hcl129$1,670
Methocarbamol82$1,137
Tramadol Hcl168$1,092
Duloxetine Hcl50$723
Topiramate67$658
Cyclobenzaprine Hcl34$554
Amitriptyline Hcl38$537
Hydromorphone Hcl21$368
Diclofenac Sodium11$342
ProgesteroneProgesterone, Micronized23$338
Baclofen16$328

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →